- Evaluation of the UniCel(TM) DxI 800 Immunoassay Analyzer in Measuring Five Tumor Markers
-
Park Y, Park Y, Park J, Kim HS
- KMID: 1776991
- Yonsei Med J.
- 2012 May;53(3):557-564.
- doi: 10.3349/ymj.2012.53.3.557
PURPOSE: Tumor marker concentrations in a given specimen measured by different analyzers vary according to assay methods, epitopes for antibodies used, and reagent specificities. Although great effort in quality assessment... -
- CITED
-
- Close
- SHARE
-
- Close
- Selected Adnexal Cystic Masses in Postmenopausal Women Can be Safely Managed by Laparoscopy
-
Lee JW, Kim CJ, Lee JE, Lee SJ, Kim BG, Lee JH, Bae DS, Park CS
- KMID: 1778508
- J Korean Med Sci.
- 2005 Jun;20(3):468-472.
- doi: 10.3346/jkms.2005.20.3.468
The aim of this study was to assess the efficacy and safety of laparoscopic treatment for adnexal cystic masses that were predicted to be benign in postmenopausal women. Postmenopausal women... -
- CITED
-
- Close
- SHARE
-
- Close
- Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findings
-
Wilailak S, Chan KK, Chen CA, Nam JH, Ochiai K, Aw TC, Sabaratnam S, Hebbar S, Sickan J, Schodin BA, Charakorn , Sumpaico W
- KMID: 2158802
- J Gynecol Oncol.
- 2015 Jan;26(1):46-53.
- doi: 10.3802/jgo.2015.26.1.46
OBJECTIVE: The purpose of this study was to develop a risk prediction score for distinguishing benign ovarian mass from malignant tumors using CA-125, human epididymis protein 4 (HE4), ultrasound findings,... -
- CITED
-
- Close
- SHARE
-
- Close
- Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments
-
Mitamura T, Watari H, Todo Y, Kato T, Konno Y, Hosaka M, Sakuragi N
- KMID: 2130118
- J Gynecol Oncol.
- 2014 Oct;25(4):301-305.
- doi: 10.3802/jgo.2014.25.4.301
OBJECTIVE: According to the International Federation of Gynecology and Obstetrics staging, some surgeons perform lymphadenectomy in all patients with early stage endometrial cancer to enable the accurate staging. However, there... -
- CITED
-
- Close
- SHARE
-
- Close
- High expression of epidermal growth factor-like domain 7 is correlated with poor differentiation and poor prognosis in patients with epithelial ovarian cancer
-
Oh J, Park SH, Lee TS, Oh HK, Choi JH, Choi YS
- KMID: 2130123
- J Gynecol Oncol.
- 2014 Oct;25(4):334-341.
- doi: 10.3802/jgo.2014.25.4.334
OBJECTIVE: The purpose of this study was to evaluate the expression of epidermal growth factor-like domain 7 (EGFL7) in epithelial ovarian cancer, and to assess its relevance to clinicopathological characteristics... -
- CITED
-
- Close
- SHARE
-
- Close
- Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates
-
Helpman L, Zidan O, Friedman E, Kalfon S, Perri T, Ben-Baruch G, Korach J
- KMID: 2413221
- J Gynecol Oncol.
- 2017 Sep;28(5):e61.
- doi: 10.3802/jgo.2017.28.e61
OBJECTIVE: The current study investigates disease patterns and outcomes in young Israeli epithelial ovarian cancer (EOC) patients and their association with BRCA mutation status. METHODS: Consecutive EOC patients diagnosed at or... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Characteristics of Metastatic Tumors to the Ovaries
-
Lee SJ, Bae JH, Lee AW, Tong SY, Park YG, Park JS
- KMID: 1794416
- J Korean Med Sci.
- 2009 Feb;24(1):114-119.
- doi: 10.3346/jkms.2009.24.1.114
Approximately 5-30% of the ovarian cancers are metastatic malignancies. The prevalence of metastatic ovarian tumors varies with the incidence rates and spread patterns of primary malignancies. We evaluated the prevalence,... -
- CITED
-
- Close
- SHARE
-
- Close
